Asthma Therapeutics Market Size Is Anticipated To Reach US$ 20.4 Billion at a CAGR of 1.9% By 2028, Rise in number of respiratory disease cases | GlaxoSmithKline Plc., Philips Healthcare, AstraZeneca Plc

Overview:

Asthma is a chronic respiratory disease characterized by recurrent attacks of breathlessness and wheezing, which may vary in frequency and severity from person to person. Asthma can occur at any stage, although it is the most common in children. Asthma attacks linked to respiratory infections and environmental factors, such as smoke, tobacco, allergens, and indoor-outdoor pollution. These factors are responsible for the development and exacerbation of asthma.

Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/2698

Drives:

Increasing prevalence of respiratory disease, such as asthma, around the world is expected to propel growth of the global asthma therapeutics market over the forecast period. For instance, as per the World Health Organization’s 2016 report, each year, more than 235 million people worldwide suffer from asthma.

Moreover, increasing awareness among people about available asthma therapeutics is expected to fuel growth of the global asthma therapeutics market. For instance, in May 2019, Koninklijke Philips launched a campaign, Help Your Child Fight against Asthma, to raise awareness among people about asthma and related respiratory diseases.

Restraints:

Product recalls are expected to hamper growth of the global asthma therapeutics market. For instance, in August 2018, the U.S. Food and Drug Administration (FDA) issued a voluntary recall for Camber Pharmaceuticals’ Montelukast Sodium Tablets, after packaging the wrong medicines into bottles that were issued to health care providers and pharmacists.

Market Taxonomy:

By Drug Class:

• Corticosteroids
• Beta2-Agonists (Long-acting and Short-acting)
• Leukotriene Inhibitors
• Long-acting Muscarinic Antagonists (LAMA)
• Interleukin Antagonists
• Anti-immunoglobulin E (IgE) Agents
• Combination Products (Including Beta2 Agonists/Corticosteroids
• Beta2 Agonists/Muscarinic Antagonists/Corticosteroids

By Route of Administration:

• Oral
• Inhalation
• Injection

By Distribution Channel:

• Hospitals Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

Get Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/2698

Regional Insights:

North America is expected to witness robust growth in the global asthma therapeutics market owing to the frequent approvals and launches in the region. For instance, Novartis announced that the FDA approved Xolair (containing-Omalizumab) prefilled syringe formulation to treat allergic asthma. Moreover, in October 2018, Regeneron Pharmaceuticals announced that the FDA approved Dupixent (contains- Dupilumab) to treat and prevent pulmonary/respiratory diseases including moderate-to-severe asthma.

Furthermore, Asia Pacific is also expected to witness significant growth in the global asthma therapeutics market due to the increasing product launches in this region. For instance, in April 2019, Cipla Friday announced the launch of proprietary respiratory inhalation therapy product ‘Niveoli’ in India for adults. It is designed to treat obstructive airways diseases (OAD), such as Chronic Obstructive Pulmonary Disease (COPD) and asthma.

Competitive Landscape:

• Roche Diagnostics
• Merck & Co.
  Inc.
• CareFusion Corporation
• Sanofi-Aventis
• Boehringer Ingelheim GmbH
• Philips Healthcare
• GlaxoSmithKline
• AstraZeneca Plc.
• Sunovion Pharmaceuticals
  Inc.
• Teva Pharmaceutical Industries Ltd.
  among others.

Direct Purchase This Report with Access of full Information @ https://www.coherentmarketinsights.com/insight/buy-now/2698

Reasons to Purchase This Report

• Current and future of Asthma Therapeutics Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

Table of Contents

1. Research Objective and Assumption

1. • Research Objectives
   • Assumptions

• • Abbreviations

2. Market Overview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Drug Class
     • Market Snippet, By Route of Administration
     • Market Snippet, By Distribution Channel
     • Market Snippet, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Market Trends
   • Key Developments
   • Technology Advancements
   • Epidemiology
   • Product Recalls
   • Government Initiatives
   • Historical Overview
   • Merger and Acquisition
   • Regulatory and Reimbursement Scenario
   • PORTER’S Five Forces
   • PEST Analysis
4. Global Asthma Therapeutics Market, By Drug Class, 2018 – 2026, (US$ Million)
   • Introduction
     • Market Share Analysis, 2018 and 2026 (%)
     • Y-o-Y Growth Analysis, 2017 – 2026
     • Segment Trends
   • Corticosteroids
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
   • Beta2-Agonists (Long-Acting and Short-Acting)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)

1. • Leukotriene Inhibitors
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million
   • Long-Acting Muscarinic Antagonists (LAMA)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million
   • Interleukin Antagonists
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million
   • Anti-Immunoglobulin E (IgE) Agents
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million
   • Combination Products (Including Beta2 Agonists/Corticosteroids, Beta2 Agonists/Muscarinic Antagonists/Corticosteroids and Others)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million

5. Global Asthma Therapeutics Market, By Route of Administration, 2018 – 2026, (US$ Million)
   • Oral

1. • • Introduction

• • • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million
  • Inhalation
    • Introduction

1. • • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million

• • Injection

1. • • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million

6. Global Asthma Therapeutics Market, By Distribution Chanel, 2018 – 2026, (US$ Million)
   • Introduction

1. • • Market Share Analysis, 2018 and 2026 (%)
     • Y-o-Y Growth Analysis, 2017 – 2026
     • Segment Trends
   • Hospitals Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)

7. Global Asthma Therapeutics Market, By Region, 2018 – 2026, (US$ Million)

1. • Introduction
     • Market Share Analysis, By Region, 2018 and 2026 (%)
     • Y-o-Y Growth Analysis, By Region, 2017 – 2026
     • Regional Trends
   • North America
     • Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Million)
     • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
     • Market Size and Forecast By Country, 2016 – 2026, (US$ Million)

• • • • US.
      • Canada

1. • Europe

• • • • UK.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe

1. • Asia Pacific

• • • • China
      • Japan
      • India
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific

1. • Latin America

• • • • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America

1. • Africa

• • • • North Africa
      • Central Africa
      • South Africa

1. • Middle East

• • • • GCC Countries
      • Israel
      • Rest of Middle East